compound semaglutide fda ends shortage, closing the door on compounded Wegovy, Ozempic Compound versions of GLP-1 drugs

However, it usually subsides as your body adjusts

Resistance training complements nutrition to protect metabolic rate and preserve muscle

The SURMOUNT-1 trial showed participants losing up to 22.5% of their body weight on the highest dose, compared to approximately 15-17% with semaglutide in the STEP trials

Retatrutide vs Mounjaro: the big difference Here's the headline: Mounjaro = dual agonist (2 targets) Retatrutide = triple agonist (3 targets) So retatrutide has an "extra lever" (the glucagon receptor) on top of the GLP1 and GIP effects

Ethics declarations Conflict of interest SC received lecture or consultancy fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, MSD, Novo Nordisk

Hims & Hers Reviews Public review themes remain mixed